Valproic Acid at Therapeutic Plasma Levels May Increase 5-Azacytidine Efficacy in Higher Risk Myelodysplastic SyndromesMaria Teresa Voso, Giuseppe Leone, Carlo Finelli et al.|Clinical Cancer Research|2009Cited by 101